Inductive
Inductive Bio is a New York-based AI drug discovery company building a virtual lab for small molecule optimization. It pairs medicinal chemists with AI to run millions of in silico ADMET experiments before synthesis. Its Beacon-1 models — trained on a pre-competitive, anonymized data consortium spanning thousands of drug programs — won consecutive first-place finishes in the 2025 Polaris/ASAP and 2026 OpenADMET blind ADMET prediction competitions, beating 370+ submissions including entries from Merck and NVIDIA. Products include the Compass software platform (accessible via API), the Indy AI chemistry assistant, the ADME-One high-throughput profiling service, and Embedded Experts. Founded in 2023 by Josh Haimson and Ben Birnbaum (both formerly Flatiron Health); SOC 2 compliant; backed by Obvious Ventures, a16z Bio+Health, Lux Capital, Bessemer Venture Partners, Character, and S32.
Inductive is profiled on the APIs.io network. Tagged areas include Company, Artificial Intelligence, Machine-Learning, Drug Discovery, and Biotechnology.
Inductive’s developer surface includes engineering blog and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Company 2
The organization behind the API